Macquarie Group LTD Lexicon Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$3.45 - $9.09 $40,354 - $106,325	-11,697 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$3.16 - $5.15 $1.39 Million - $2.26 Million	-438,303 Reduced 97.4%	11,697 $49,000
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $1.96 Million - $3.57 Million	450,000 New	450,000 $2.5 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $145M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.